2.36 USD
↘ 0.16 (6.31%)PRE MARKET (AS OF 03:45 AM EST)
Niagen Bioscience, Inc. Common Stock
NAGENASDAQ • USD
Market: OPEN
Shares of Niagen Bioscience, Inc. Common Stock (NAGE) are trading at $2.36. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 4, 2026.
Open?N/A
High?N/A
Low?N/A
Prev. Close?$2.52
Volume?0
Avg. Volume?557.0K
Bid / Ask
Bid?$2.18 × 100
Ask?$2.93 × 100
Spread?$0.75
Midpoint?$2.56
Valuation & Ratios
Market Cap?199.4M
Shares Out?79.6M
Float?51.9M
Float %?65.1%
P/E Ratio?12.47
P/B Ratio?2.42
EPS?$0.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Employees
117
Market Cap
199.4M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Website
Listed
2008-06-24
Address
10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
Phone: 310-388-6706
LOS ANGELES, CA 90024
Phone: 310-388-6706
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?10
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?5.38Safe
Confidence?40%Low
Short InterestHigh
Short % of Float?8.05%Elevated
Short Interest?4.2M
Days to Cover?6.2
Free Float51.9M
Avg Daily Volume675.0K
Settlement Date2026-10-15
Financial Health
Current Ratio?6.50Strong
Quick Ratio?5.13Strong
Cash Ratio?4.43Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score89/100
P/E?12.5CHEAP▾
Peers100
S&P90
P/B?2.42CHEAP▾
Peers100
S&P66
P/S?1.54CHEAP▾
Peers100
S&P78
P/FCF?35.1PRICEY▾
Peers100
S&P21
EV/EBITDA?11.5CHEAP▾
Peers100
S&P71
EV/Sales?1.03CHEAP▾
Peers100
S&P91
Returns & Efficiency
ROE?19.4%STRONG▾
Peers50
S&P65
ROA?15.0%STRONG▾
Peers50
S&P87
Cash Flow & Enterprise
FCF?$5.7M
Enterprise Value?$132.7M
Fundamentals ratios updated end of day